Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INCY

Incyte (INCY)

Incyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INCY
DateTimeSourceHeadlineSymbolCompany
02/16/202412:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/16/202412:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/16/202412:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/16/202412:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/16/202412:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/16/202412:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/15/20248:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
02/14/202412:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
02/13/20245:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INCYIncyte Corporation
02/13/20244:03PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INCYIncyte Corporation
02/13/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INCYIncyte Corporation
02/13/20247:00AMBusiness WireIncyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D PrioritiesNASDAQ:INCYIncyte Corporation
02/06/20244:08AMBusiness WireIncyte erhält exklusive weltweite Rechte für die Entwicklung und Vermarktung von Tafasitamab (Monjuvi ® )NASDAQ:INCYIncyte Corporation
02/05/20248:55PMBusiness WireIncyte obtient les droits exclusifs de développement et de commercialisation du tafasitamab (Monjuvi®) à l’échelle mondialeNASDAQ:INCYIncyte Corporation
02/05/20244:46PMBusiness WireIncyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)NASDAQ:INCYIncyte Corporation
01/24/20242:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/24/20242:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/24/20249:46AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INCYIncyte Corporation
01/23/20248:00AMBusiness WireIncyte to Report Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:INCYIncyte Corporation
01/22/20241:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/22/20241:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/19/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
01/19/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY